Thu, December 22, 2011
[ Thu, Dec 22nd 2011 ] - Market Wire
Valeant Pharmaceuticals Completes Acquisition of iNova
[ Thu, Dec 22nd 2011 ] - Market Wire
Curis Announces Collaborator Rocheas Submission o .. lication for Vismodegib in Advanced Basal Cell Ca
[ Thu, Dec 22nd 2011 ] - Market Wire
AVEO Announces Patient Enrollment in Phase 2 Clin .. mbination with mFOLFOX6 in Patients with Advanced
Wed, December 21, 2011
[ Wed, Dec 21st 2011 ] - Market Wire
Anika Therapeutics Announces U.S. MONOVISC License and Supply Agreement with DePuy Mitek, Inc.
[ Wed, Dec 21st 2011 ] - Market Wire
New VIP Program Makes It Easier to Join Reliv
[ Wed, Dec 21st 2011 ] - Market Wire
Emergent BioSolutions Announces Fuad El-Hibri to .. cutive Chairman of the Board of Directors Focused
[ Wed, Dec 21st 2011 ] - Market Wire
Neogen Corporation Announces 2nd Quarter Results Conference Call
[ Wed, Dec 21st 2011 ] - Market Wire
Heska Corporation Awards $25,000 Grand Prize to Belize Wildlife & Referral Center
[ Wed, Dec 21st 2011 ] - Market Wire
Hill-Rom to Participate in the 30th Annual J.P. Morgan Healthcare Conference
[ Wed, Dec 21st 2011 ] - Market Wire
Dynavax and AstraZeneca Agree to Conduct Toxicology Studies for TLR-9 Agonist for Asthma
[ Wed, Dec 21st 2011 ] - Market Wire
Kedem Pharmaceuticals Inc. Trading Under Symbol KDMP.ob and Introducing a New Website
[ Wed, Dec 21st 2011 ] - Market Wire
Crystal Research Associates, LLC Issues Executive .. rview (EIO) on InVivo Therapeutics Holdings Corp.
[ Wed, Dec 21st 2011 ] - Market Wire
OPKO Health To Acquire FineTech Pharmaceutical Ltd.
[ Wed, Dec 21st 2011 ] - Market Wire
Impax Pharmaceuticals Submits New Drug Application for IPX066 in Parkinsonas Disease
[ Wed, Dec 21st 2011 ] - Market Wire
Celldex Completes Accrual of CDX-011 Phase 2b aEMERGEa Study in Advanced Breast Cancer
[ Wed, Dec 21st 2011 ] - Market Wire
Ligand Enters into Platform Captisol License and Supply Agreements with Lilly
[ Wed, Dec 21st 2011 ] - Market Wire
PharmaGap Completes In Vivo Study Protocol in Ovarian Cancer
[ Wed, Dec 21st 2011 ] - Market Wire
IBEX Reports First Quarter Fiscal 2012 Results
[ Wed, Dec 21st 2011 ] - Market Wire
Repligen Announces Submission of New Drug Applica .. ved Pancreatic Imaging In Patients with Pancreati
[ Wed, Dec 21st 2011 ] - Market Wire
Titan Pharmaceuticals Adopts Stockholder Rights P .. iles Shelf Registration of Securities on Form S-3
[ Wed, Dec 21st 2011 ] - Market Wire
Implant Sciences' Quantum Sniffer QS-B220 Achieves CE Certification
[ Wed, Dec 21st 2011 ] - Market Wire
Adeona Announces Proposed Name Change to Syntheti .. tment of John Monahan, Ph.D., as Senior Vice Pres
[ Wed, Dec 21st 2011 ] - Market Wire
Strategic Global Investments, Inc. Announces Alli .. ce Support, Corp., Preferred Provider of Anheuser
[ Wed, Dec 21st 2011 ] - Market Wire
Exelixis Licenses PI3K-Delta Program to Merck
[ Wed, Dec 21st 2011 ] - Market Wire
Capital Senior Living Corporation to Present at S .. l Micro-Cap Conference on Monday, January 9, 2012
[ Wed, Dec 21st 2011 ] - Market Wire
PAREXEL Introduces Executive Briefing Series on P .. erging and Mid-size Biopharma in Achieving Better
[ Wed, Dec 21st 2011 ] - Market Wire
Denali Concrete Management Inc. Announces the Com .. Enrollment for the Phase 3 Dry Eye Syndrome Study
[ Wed, Dec 21st 2011 ] - Market Wire
Matthew Hunt Appointed Managing Director, Health Services, Aetna International
Tue, December 20, 2011
[ Tue, Dec 20th 2011 ] - Market Wire
Mindray Signs Agreement With Novation
[ Tue, Dec 20th 2011 ] - Market Wire
SecureAlert Receives Prestigious Deloitte 2011 Te .. s One of the "Fastest Growing Companies in Americ
[ Tue, Dec 20th 2011 ] - Market Wire
Amerigroup Foundation Presents Grant to Empty Stocking Fund
[ Tue, Dec 20th 2011 ] - Market Wire
Bard Acquires Lutonix, Inc.
[ Tue, Dec 20th 2011 ] - Market Wire
Healthways Revises Financial Guidance for 2011
[ Tue, Dec 20th 2011 ] - Market Wire
Masimo to Present at 30th Annual J.P. Morgan Healthcare Conference
[ Tue, Dec 20th 2011 ] - Market Wire
Salix Pharmaceuticals Completes Acquisition of Oceana Therapeutics
[ Tue, Dec 20th 2011 ] - Market Wire
OPKO Health Announces Commencement of U.S. Clinic .. for Point-of-Care Prostate Specific Antigen Test
[ Tue, Dec 20th 2011 ] - Market Wire
Isis Pharmaceuticals Announces Its R&D Webcast Presentation
[ Tue, Dec 20th 2011 ] - Market Wire
Imaging Diagnostic Sells Its CTLM System to China
[ Tue, Dec 20th 2011 ] - Market Wire
Allezoe Medical Holdings (ALZM) Completes Exclusive Licensing Deal for HPV Diagnostic Technology
[ Tue, Dec 20th 2011 ] - Market Wire
Dynavax Initiates Proof of Mechanism Trial in Lupus Patients
[ Tue, Dec 20th 2011 ] - Market Wire
Repligen Completes Acquisition of Novozymes Biopharma Sweden AB
[ Tue, Dec 20th 2011 ] - Market Wire
Prestige Brands Holdings, Inc. Signs Definitive A .. 17 Consumer OTC Healthcare Brands in North Ameri
[ Tue, Dec 20th 2011 ] - Market Wire
Oncothyreon Files Investigational New Drug Application for ONT-10
[ Tue, Dec 20th 2011 ] - Market Wire
Pfizer Announces FDA Acceptance For Review Of New .. inib For Adult Patients With Moderately To Severe
[ Tue, Dec 20th 2011 ] - Market Wire
Molinaas Medicaid Claims Processing System Receives Full Federal Certification in Maine
[ Tue, Dec 20th 2011 ] - Market Wire
Mylan Receives WHO Approval for Innovative 'Second-Line-in-a-Box' HIV/AIDS Treatment
[ Tue, Dec 20th 2011 ] - Market Wire
Warnex to Sell Its Analytical Services Division
[ Tue, Dec 20th 2011 ] - Market Wire
Implant Sciences' Quantum Sniffer QS-B220 Receive .. for TSA Air Cargo Screening Qualification Testin
[ Tue, Dec 20th 2011 ] - Market Wire
Salix and Progenics Announce Positive Highly Stat .. of Oral Methylnaltrexone for Phase 3 Trial in Ch
[ Tue, Dec 20th 2011 ] - Market Wire
Covidien annuncia marchio CE per software Nellcora" Respiration Rate
[ Tue, Dec 20th 2011 ] - Market Wire
Agenus and NewVac Enter Into Agreement in the Area of Personalized Cancer Vaccines
[ Tue, Dec 20th 2011 ] - Market Wire
Covidien annonce le marquage CE de son logiciel N .. cora" de surveillance de la frquence respiratoire
[ Tue, Dec 20th 2011 ] - Market Wire
Covidien meldet CE-Kennzeichnung fr Nellcora" Respiration Rate Software
Mon, December 19, 2011
[ Mon, Dec 19th 2011 ] - Market Wire
TPI Attends 30th J.P. Morgan Healthcare Conference at San Francisco
[ Mon, Dec 19th 2011 ] - Market Wire
Health Management Associates Names Mike Fencel as .. Chief Executive Officer of North Florida Division
[ Mon, Dec 19th 2011 ] - Market Wire
Life Technologies to Present at Upcoming Investment Conferences in January
[ Mon, Dec 19th 2011 ] - Market Wire
The Law Firm of Levi & Korsinsky, LLP Launches an .. Securities Laws Violations by Invacare Corporatio
[ Mon, Dec 19th 2011 ] - Market Wire
Bronstein, Gewirtz & Grossman, LLC Announces Investigation into Invacare Corporation
[ Mon, Dec 19th 2011 ] - Market Wire
Imaging Diagnostic Systems Assigns ID-Matrix Systems as Exclusive Distributor for China
[ Mon, Dec 19th 2011 ] - Market Wire
Southern California Investment Forum Hosts an Inv .. hering Today at the Pacific Club in Newport Beach
[ Mon, Dec 19th 2011 ] - Market Wire
BioElectronics Announces Chinese Patent
[ Mon, Dec 19th 2011 ] - Market Wire
Unigene's 2011 Year in Review - Key Elements in Place to Address Debt in 2012
[ Mon, Dec 19th 2011 ] - Market Wire
Zimmer Initiates Quarterly Dividend and Announces New Share Repurchase Program
[ Mon, Dec 19th 2011 ] - Market Wire
Kindred Healthcare Promotes Patricia M. Henry to President of RehabCare Division
[ Mon, Dec 19th 2011 ] - Market Wire
Vermillion Completes the Acquisition of Correlogic Systems' Ovarian Cancer Diagnostics Business
[ Mon, Dec 19th 2011 ] - Market Wire
Cytori Completes IDE Filing for Chronic Myocardial Ischemia ATHENA Trial of the Celution(R) System
[ Mon, Dec 19th 2011 ] - Market Wire
Valeant Pharmaceuticals Completes Acquisition of Dermik
[ Mon, Dec 19th 2011 ] - Market Wire
Ardea Biosciences Initiates Phase 3 Clinical Development Program for Lesinurad
[ Mon, Dec 19th 2011 ] - Market Wire
Galectin Therapeutics Provides Corporate Update
[ Mon, Dec 19th 2011 ] - Market Wire
Somaxon Pharmaceuticals Hires Financial Advisor to Assist in Seeking Strategic Alternatives
[ Mon, Dec 19th 2011 ] - Market Wire
Isis Initiates Phase 1 Clinical Study of ISIS-SMNRx in Patients With Spinal Muscular Atrophy
[ Mon, Dec 19th 2011 ] - Market Wire
Equity Research on St. Jude Medical Inc. and Medt .. nt Cutbacks Affecting Medical Appliances &;
[ Mon, Dec 19th 2011 ] - Market Wire
Leading U.S. Healthcare Providers Ordering Sequenom Center for Molecular Medicine's MaterniT21 LDT
[ Mon, Dec 19th 2011 ] - Market Wire
Pharmacyclics Inc. Receives Issue Notice of Significant Bruton's Tyrosine Kinase (BTK) Patent
[ Mon, Dec 19th 2011 ] - Market Wire
PDL BioPharma Provides Fourth Quarter 2011 Revenue Guidance of $72 Million
[ Mon, Dec 19th 2011 ] - Market Wire
Pacira Pharmaceuticals, Inc. Announces Results fr .. Trial Published in Diseases of the Colon & Rectum
[ Mon, Dec 19th 2011 ] - Market Wire
DDC, One of the Largest DNA Testing Companies Wor .. the Acquisition of Orchid Cellmark's Government P
[ Mon, Dec 19th 2011 ] - Market Wire
Perceptive Informatics DataLabs EDC Solution Impl .. 15 of the Top Global Biopharmaceutical Companies
Sun, December 18, 2011
[ Sun, Dec 18th 2011 ] - Market Wire
Galapagos achieves clinical Proof-of-Mechanism milestone in GSK alliance
Sat, December 17, 2011
[ Sat, Dec 17th 2011 ] - Market Wire
Bull & Lifshitz, LLP Announces Investigation of Synovis Life Technologies, Inc.
Fri, December 16, 2011
[ Fri, Dec 16th 2011 ] - Market Wire
HealthSouth to Present at the 30th Annual J.P. Morgan Healthcare Conference
[ Fri, Dec 16th 2011 ] - Market Wire
Mylan Launches Generic Version of Toprol-XL Tablets
[ Fri, Dec 16th 2011 ] - Market Wire
Herbalife statement regarding Belgian Commercial Court Ruling
[ Fri, Dec 16th 2011 ] - Market Wire
St. Jude Medical meldt eerste implantatie in Euro .. ch onderzoek naar Portico transcatheter aortaklep
[ Fri, Dec 16th 2011 ] - Market Wire
Genomsequenzierung frdert Forschung auf dem Gebie .. weit verbreiteten Volkskrankheiten in Frankreich.
[ Fri, Dec 16th 2011 ] - Market Wire
Humana Military Makes the Holidays Brighter for Children
[ Fri, Dec 16th 2011 ] - Market Wire
ARIAD Announces Underwritersa Exercise of Over-Allotment Option
[ Fri, Dec 16th 2011 ] - Market Wire
Dehaier Medical Enters European Homecare Medical Product Market
[ Fri, Dec 16th 2011 ] - Market Wire
Landmark Publication Endorses Prana's Drug Pipeli .. Strategy for Treating Neurodegenerative Diseases
[ Fri, Dec 16th 2011 ] - Market Wire
Ariad, Delta Air Lines, BioSante, Bank of America, Boston Scientific and News Corp
[ Fri, Dec 16th 2011 ] - Market Wire
Catasys Adds Another Customer in Massachusetts
[ Fri, Dec 16th 2011 ] - Market Wire
AtriCureas Synergy Ablation System Receives FDA Approval for the Treatment of Atrial Fibrillation
[ Fri, Dec 16th 2011 ] - Market Wire
Underperforming Medtronic and Allezoe Medical Look to Turn Around Fortunes in 2012
[ Fri, Dec 16th 2011 ] - Market Wire
Recent FDA Approvals for Antares Pharma and Boston Scientific Have Done Little to Boost Shares
[ Fri, Dec 16th 2011 ] - Market Wire
China Sky One Medical to Jointly Launch Adult Stem Cell Research Enterprise
[ Fri, Dec 16th 2011 ] - Market Wire
Trimel to Present Anorgasmia (FSD) Phase II Clinical Trial Results
[ Fri, Dec 16th 2011 ] - Market Wire
Valeant Pharmaceuticals Proposes to Acquire ISTA Pharmaceuticals Inc. for $6.50 Per Share in Cash
[ Fri, Dec 16th 2011 ] - Market Wire
Kensey Nash to Enter Into Mediation with St. Jude Medical over Angio-Seal Contract Disputes
[ Fri, Dec 16th 2011 ] - Market Wire
Pfizer Broadens and Extends Commitment to Help Pr .. Infants and Young Children in the Worldas Poores
[ Fri, Dec 16th 2011 ] - Market Wire
Thoratec Announces Appointment of William A. Hawkins to Board of Directors
[ Fri, Dec 16th 2011 ] - Market Wire
Valeant Announces Successful Results From Phase III Onychomycosis Trials
[ Fri, Dec 16th 2011 ] - Market Wire
La secuenciacin del genoma ayuda a la investigacin de las enfermedades pblicas en Francia
[ Fri, Dec 16th 2011 ] - Market Wire
Concord Medical to Present at the 30th Annual J.P. Morgan Healthcare Conference in January 2012
[ Fri, Dec 16th 2011 ] - Market Wire
Centene Corporation Announces 2012 Financial Guidance
Thu, December 15, 2011
[ Thu, Dec 15th 2011 ] - Market Wire
Die US-Arzneimittelbehrde FDA hat einem beschleun .. KALYDECOa" (Ivacaftor) zugestimmt, das erste pote
[ Thu, Dec 15th 2011 ] - Market Wire
Pomerantz Law Firm Investigates Claims on Behalf of Investors of SonoSite, Inc.
[ Thu, Dec 15th 2011 ] - Market Wire
The Law Firm of Levi &;; Korsinsky, LLP .. of Breaches of Fiduciary Duty by the Board of Sy
[ Thu, Dec 15th 2011 ] - Market Wire
Rigrodsky & Long, P.A. Announces Investigation of .. ite, Inc.as Sale to Fujifilm Holdings Corporation
[ Thu, Dec 15th 2011 ] - Market Wire
St. Jude gibt erste Implantation der Transkathete .. ahmen einer europischen klinischen Studie bekannt
[ Thu, Dec 15th 2011 ] - Market Wire
Orexigen Therapeutics Prices Public Offering of Common Stock and Warrants to Purchase Common Stock
[ Thu, Dec 15th 2011 ] - Market Wire
Critical Stock Alerts for Eli Lilly, NVIDIA, Inte .. mana Gold, Charles Schwab, and MF Global Holdings
[ Thu, Dec 15th 2011 ] - Market Wire
Vista Partners Updates Coverage on ADVENTRX Pharmaceuticals, Inc.;; $3.50 Target Price
[ Thu, Dec 15th 2011 ] - Market Wire
TheraBiogen Announces National Cable Television Ad Campaign Launches YouTube Page
[ Thu, Dec 15th 2011 ] - Market Wire
p-Value Capital Management, LLC Comments on Results of Myrexis, Inc. Shareholder Vote
[ Thu, Dec 15th 2011 ] - Market Wire
Graymark Healthcare Closes Acquisition of Village Sleep Center in Plano, Texas
[ Thu, Dec 15th 2011 ] - Market Wire
New Management Changes Poise USANA for Further Growth
[ Thu, Dec 15th 2011 ] - Market Wire
Covidien meldt conference call en webcast
[ Thu, Dec 15th 2011 ] - Market Wire
Gruppo di ricerca per il linfoma negli adulti (GE .. LIMID per studio sul secondo tipo di linfoma pi c
[ Thu, Dec 15th 2011 ] - Market Wire
Covidien annuncia una teleconferenza e trasmissione web
[ Thu, Dec 15th 2011 ] - Market Wire
Arrowhead to Report Fiscal 2011 Fourth Quarter and Year-End Financial Results
[ Thu, Dec 15th 2011 ] - Market Wire
Covidien plant Ausgliederung des Unternehmensbereichs Pharmazeutika
[ Thu, Dec 15th 2011 ] - Market Wire
Covidien envisage une scission de sa branche Pharmacie
[ Thu, Dec 15th 2011 ] - Market Wire
Soligenix Initiates Next Generation Anthrax Vacci .. t Program Under Agreement With Harvard University
[ Thu, Dec 15th 2011 ] - Market Wire
SciClone Pharmaceuticals Announces Final Settlement of Stockholder Derivative Litigation
[ Thu, Dec 15th 2011 ] - Market Wire
Implant Sciences Sells Over $200,000 of Quantum S .. s Trace Detectors for Building Security in Mexico
[ Thu, Dec 15th 2011 ] - Market Wire
Importante grupo cooperativo de investigacin sobr .. elige REVLIMID para el estudio del segundo subtip
[ Thu, Dec 15th 2011 ] - Market Wire
Perceptive Informatics Completes Over 500 System .. Industry Continues to Adopt Seamless eClinical S
[ Thu, Dec 15th 2011 ] - Market Wire
Illumina Hires Laura Lauman as Vice President of Marketing
Wed, December 14, 2011
[ Wed, Dec 14th 2011 ] - Market Wire
Isis Adds Three New Drugs to Its Development Pipeline
[ Wed, Dec 14th 2011 ] - Market Wire
AVI BioPharma Receives NASDAQ Notice of Minimum Bid Price Non-Compliance
[ Wed, Dec 14th 2011 ] - Market Wire
Anthera Announces Completion of Safety Review by DSMB for VISTA-16
[ Wed, Dec 14th 2011 ] - Market Wire
BioSante Pharmaceuticals Announces Results from LibiGel Efficacy Trials
[ Wed, Dec 14th 2011 ] - Market Wire
Hospira to Present at the J.P. Morgan 30th Annual Healthcare Conference Jan. 10, 2012
[ Wed, Dec 14th 2011 ] - Market Wire
ViroPharma Announces Approval of Modernized Label .. Vancocin (vancomycin hydrochloride, USP) Capsules
[ Wed, Dec 14th 2011 ] - Market Wire
Positron's Attrius Receives Health Canada Approval
[ Wed, Dec 14th 2011 ] - Market Wire
AIM Honored for Innovative Program That Helps Consumers Make Better Choices About Their Care
[ Wed, Dec 14th 2011 ] - Market Wire
Vooraanstaande samenwerkingsgroep voor lymfoomond .. ) kiest REVLIMID voor onderzoek naar tweede meest
[ Wed, Dec 14th 2011 ] - Market Wire
Amica Mature Lifestyles Announces Closing of Subs .. cluding Exercise in Full of Over-Allotment Option
[ Wed, Dec 14th 2011 ] - Market Wire
Amgen Announces Final Results of Its Tender Offer
[ Wed, Dec 14th 2011 ] - Market Wire
St. Jude Medical annuncia il primo impianto nella .. clinica per la valutazione dalla valvola cardiac
[ Wed, Dec 14th 2011 ] - Market Wire
CytoSorbents Awarded US Army SBIR Trauma Grant
[ Wed, Dec 14th 2011 ] - Market Wire
Definitieve fase 2 gegevens van evaluatie REVLIMI .. et recidiverende of refractaire chronische lymfat
[ Wed, Dec 14th 2011 ] - Market Wire
Datos finales de la Fase II que evalan REVLIMID y .. eucemia linfoctica crnica recurrente o resistente
[ Wed, Dec 14th 2011 ] - Market Wire
Premiere Cooperative Group in Adult Lymphoma Rese .. for Study in Second Most Common Lymphoma Subtype
[ Wed, Dec 14th 2011 ] - Market Wire
Salix Pharmaceuticals Announces NDA Submission fo .. emer for the Treatment of HIV-Associated Diarrhea
[ Wed, Dec 14th 2011 ] - Market Wire
Meta-analysis of Five Clinical Trials including C .. T Study Published in American Journal of Obstetri
[ Wed, Dec 14th 2011 ] - Market Wire
REVLIMID evaluado en combinacin con rituximab com .. pacientes con leucemia linfoctica crnica no trata
[ Wed, Dec 14th 2011 ] - Market Wire
Presentados en ASH los datos de un estudio de Fas .. en pacientes con mieloma indolente de alto riesgo
[ Wed, Dec 14th 2011 ] - Market Wire
OncoSec Medical Engages The Investor Relations Group
[ Wed, Dec 14th 2011 ] - Market Wire
Rsultats dfinitifs de laessai de phase II valuant .. ez les patients atteints de leucmie lymphocytaire
[ Wed, Dec 14th 2011 ] - Market Wire
Threshold Pharmaceuticals Announces Promising Pha .. Trial Results in Patients With Advanced Leukemias
[ Wed, Dec 14th 2011 ] - Market Wire
REVLIMID a t valu en combinaison avec le Rituxima .. ntiel destin aux patients atteints de leucmie lym
Tue, December 13, 2011
[ Tue, Dec 13th 2011 ] - Market Wire
Bio-Path Holdingsa Initial Phase I Data in Leukem .. s That Its Neutral Lipid Delivery Technology Anti
[ Tue, Dec 13th 2011 ] - Market Wire
Direction of Market Influences - Report Highlight .. ceutical Industries Ltd (ADR) and Sanofi SA (ADR)
[ Tue, Dec 13th 2011 ] - Market Wire
GenVec President and Chief Executive Officer Announces Retirement
[ Tue, Dec 13th 2011 ] - Market Wire
China Botanic Announces Development of New Siberian Ginseng Polysaccharide Extract Powder
[ Tue, Dec 13th 2011 ] - Market Wire
Fase 2-onderzoek evalueert klinisch profijt van p .. j eerder behandelde patinten met multipel myeloom
[ Tue, Dec 13th 2011 ] - Market Wire
Endgltige Daten aus multizentrischer Phase-II-Stu .. binationstherapie von VIDAZA und REVLIMID fr MDS-
[ Tue, Dec 13th 2011 ] - Market Wire
Nektar Announces Positive Clinical Data from Seco .. NKTR-181, a Novel Opioid Analgesic Molecule to Tr
[ Tue, Dec 13th 2011 ] - Market Wire
Stem Cell Therapeutics Announces Additions to Advisory Board
[ Tue, Dec 13th 2011 ] - Market Wire
Eindgegevens van Fase II multi-center onderzoek n .. REVLIMID bij patinten met hoogrisico MDS gepresen
[ Tue, Dec 13th 2011 ] - Market Wire
BioLineRx to Develop and Commercialize Novel Peptide Drug Candidates Discovered by Compugen
[ Tue, Dec 13th 2011 ] - Market Wire
Synergy Pharmaceuticals, Inc. reicht Klage ein ge .. Inc. und dessen Chief Scientific Officer und Sen
[ Tue, Dec 13th 2011 ] - Market Wire
Prsentation laASH des rsultats dfinitifs daune tu .. I valuant la combinaison de VIDAZA et de REVLIMID
[ Tue, Dec 13th 2011 ] - Market Wire
Une tude de phase III avec traitement continu de .. ion statistiquement considrable de la survie sans
[ Tue, Dec 13th 2011 ] - Market Wire
Phase-III-Studie mit kontinuierlicher REVLIMID-Th .. ifikante Verbesserung der progressionsfreien berl
[ Tue, Dec 13th 2011 ] - Market Wire
Threshold Pharmaceuticals Announces Update to TH- .. resented at the Oppenheimer Healthcare Conference
[ Tue, Dec 13th 2011 ] - Market Wire
NTRR Targets $390 Billion Weight Loss and Diet Management Market
[ Tue, Dec 13th 2011 ] - Market Wire
FDA Psychopharmacologic Drugs Advisory Committee Recommends Approval of Alexza's ADASUVEa"
[ Tue, Dec 13th 2011 ] - Market Wire
Radient Pharmaceuticals Launches New Onko-Sure Website, Facebook and Twitter Outreach
[ Tue, Dec 13th 2011 ] - Market Wire
Une tude de dosage value REVLIMID chez des patien .. aits, atteints de leucmie lymphocytaire chronique
[ Tue, Dec 13th 2011 ] - Market Wire
Les rsultats d'une analyse comparative rvlent que .. tistiquement significative le risque de dcs, sans
[ Tue, Dec 13th 2011 ] - Market Wire
Synergy Pharmaceuticals, Inc. dpose plainte contr .. Inc. et son conseiller scientifique en chef et VP
[ Tue, Dec 13th 2011 ] - Market Wire
Synergy Pharmaceuticals, Inc. Files Suit Against .. c. and its Chief Scientific Officer and Senior VP
[ Tue, Dec 13th 2011 ] - Market Wire
Synergy Pharmaceuticals, Inc. fa causa ad Ironwoo .. suo Direttore Scientifico e Vicepresidente Senior
[ Tue, Dec 13th 2011 ] - Market Wire
Synergy Pharmaceuticals, Inc. spant geding aan te .. , Inc. en haar Chief Scientific Officer en Senior
Mon, December 12, 2011
[ Mon, Dec 12th 2011 ] - Market Wire
Robbins Umeda LLP Announces an Investigation of Pain Therapeutics, Inc.
[ Mon, Dec 12th 2011 ] - Market Wire
Ligand Announces Positive Preclinical Data on Sma .. nist at the 53rd Annual Meeting of the American S
[ Mon, Dec 12th 2011 ] - Market Wire
Synergetics Reports Record First Quarter
[ Mon, Dec 12th 2011 ] - Market Wire
Enzo Biochem Reports Fiscal First Quarter 2012 Results
[ Mon, Dec 12th 2011 ] - Market Wire
Anacor Pharmaceuticals Announces Positive Prelimi .. a Trial of AN2728 and AN2898 in Atopic Dermatitis
[ Mon, Dec 12th 2011 ] - Market Wire
Fase 3 onderzoek naar continue behandeling met RE .. ificante verbetering in progressievrije overlevin
[ Mon, Dec 12th 2011 ] - Market Wire
Pfizer Elects CEO Ian Read As Chairman Of The Board
[ Mon, Dec 12th 2011 ] - Market Wire
Gallup and Healthways Release November 2011 Well-Being Index
[ Mon, Dec 12th 2011 ] - Market Wire
Second Self Medicated Medical Cannabis Cancer Pat .. nabis Science Brand Extracts Killing Cancer Cells
[ Mon, Dec 12th 2011 ] - Market Wire
Pharmacyclics Reports Interim Phase II Trial Resu .. 65 in Mantle Cell Lymphoma at American Society of
[ Mon, Dec 12th 2011 ] - Market Wire
Phase III Study with REVLIMID Continuous Therapy .. gnificant Improvement in Progression-Free Surviva
[ Mon, Dec 12th 2011 ] - Market Wire
Estudio de administracin evala REVLIMID en pacien .. s con anterioridad con leucemia linfoctica crnica
[ Mon, Dec 12th 2011 ] - Market Wire
Valeant Pharmaceuticals Receives Approval From FT .. ith Acquisition of Ortho Dermatologics and Dermik
[ Mon, Dec 12th 2011 ] - Market Wire
Seattle Genetics Reports Data From Multiple Prese .. RISa" (Brentuximab Vedotin) at ASH Annual Meeting
[ Mon, Dec 12th 2011 ] - Market Wire
Presentado estudio de Fase I que evala azacitidin .. cial para pacientes con leucemia mieloide grave e
[ Mon, Dec 12th 2011 ] - Market Wire
Pfizer Declares A 22-Cent First-Quarter 2012 Dividend
[ Mon, Dec 12th 2011 ] - Market Wire
Isis Reports Positive Phase 1 Data Demonstrating .. FXIRx Reduces Factor XI Activity Without Bleeding
[ Mon, Dec 12th 2011 ] - Market Wire
Sun Healthcare Group, Inc. Should Be Sold, Says Large Institutional Investor
[ Mon, Dec 12th 2011 ] - Market Wire
Cubist Pharmaceuticals Completes Acquisition of Adolor Corporation
[ Mon, Dec 12th 2011 ] - Market Wire
Abiomed 2011 Investor Day Webcast Replay Available
[ Mon, Dec 12th 2011 ] - Market Wire
Significant Insider Trading at Pharmacyclics, For .. ard, FUSE SCIENCE, Morgan Stanley and Weatherford
[ Mon, Dec 12th 2011 ] - Market Wire
City of Surrey and Diligent Board Member Services Create Paperless City Council
[ Mon, Dec 12th 2011 ] - Market Wire
LabCorp Successfully Completes Tender Offer for O .. Subsequent Offering Period to Allow for Additiona
[ Mon, Dec 12th 2011 ] - Market Wire
AdCare Health Systems Appoints David Rubenstein as Chief Operating Officer

FDA concede revisin prioritaria a KALYDECOa" (ivacaftor), el primer medicamento potencial para la causa subyacente de la fibros


//health-fitness.news-articles.net/content/2011/ .. ncial-para-la-causa-subyacente-de-la-fibros.html
Published in Health and Fitness on by Market Wire   Print publication without navigation


CAMBRIDGE, Mass.--([ ])--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) ha anunciado que la Agencia de Alimentos y Frmacos de EE.UU. (FDA en sus siglas en ingls) ha aceptado la solicitud de nuevo frmaco para KALYDECOTM (ivacaftor) y ha aceptado la solicitud de la empresa de una revisin prioritaria de seis meses. KALYDECO trata la protena defectuosa que causa la fibrosis qustica en un subgrupo de personas que viven con la enfermedad. En caso de ser aprobado, KALYDECO ser el primer tratamiento para la causa subyacente de la fibrosis qustica.

El comunicado en el idioma original, es la versin oficial y autorizada del mismo. La traduccin es solamente un medio de ayuda ydeber sercomparada con el texto en idioma original, que es la nica versin del texto que tendr validez legal.


Publication Contributing Sources